J Clin Oncol 2001, 19: 1001–7.PubMed 29. Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS: Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res 2004, 64: 1079–86.PubMedCrossRef 30. Johnson DG, Walker CL: Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 1999, 39: 295–312.PubMedCrossRef 31. Joseph J, Wajapeyee N, Somasundaram K: Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor selleck compound sodium butyrate. Int J Cancer 2005, 115: 11–8.PubMedCrossRef 32. Kitazono
M, Bates S, Fok P, Fojo T, Blagosklonny MV: The histone deacetylase inhibitor FR901228 (desipeptide) restores expression and function of pseudo-null p53. Cancer Biol Ther 2002, 1: 665–8.PubMed 33. Yashiro M, Chung YS, Nishimura S, Inoue T, Sowa M: Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as ‘soil’ for peritoneal dissemination. Cancer 1996, 77: 1668–75.PubMed 34. Shinto O, Yashiro M, Kawajiri H, et al.: Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Br J Cancer 2010, 102: 844–51.PubMedCrossRef 35. Kinugasa S, Abe S, Tachibana M, et al.: Over expression of
transforming growth factor-beta1 ON-01910 cost in scirrhous carcinoma of the stomach Mocetinostat correlates with decreased survival. Oncology 1998, 55: 582–7.PubMedCrossRef 36. Inoue T, Chung YS, Yashiro M, et al.: Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jpn J Cancer Res 1997, 88: 152–9.PubMed 37. Koyama T, Anacetrapib Yashiro M, Inoue T, et al.: TGF-beta1 secreted by gastric fibroblasts up-regulates CD44 H expression and stimulates the peritoneal
metastatic ability of scirrhous gastric cancer cells. Int J Oncol 2000, 16: 355–62.PubMed 38. Taylor MA, Parvani JG, Schiemann WP: The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neoplasia 2010, 15: 169–90.PubMedCrossRef 39. Miyazono K: Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci 2009, 85: 314–23.PubMedCrossRef 40. Gos M, Miłoszewska J, Przybyszewska M: Epithelial-mesenchymal transition in cancer progression. Postepy Biochem 2009, 55: 121–8.PubMed 41. Glenisson W, Castronovo V, Waltregny D: Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation. Biochim Biophys Acta 2007, 1773: 1572–82.PubMedCrossRef 42. Khan N, Jeffers M, Kumar S, et al.